Slate Medicines, Inc. filed a Form D with the Securities and Exchange Commission on 2026-03-11.
Slate Medicines, Inc. filed a Form D notice of an exempt securities offering with the SEC on March 11, 2026. The filing reports $10M sold. Its industry group is Pharmaceuticals. It names Andrew Levin (Director), Cindy Xiong (Director), Tim Lohoff (Director) (SEC Form D, March 11, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Slate Medicines, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-03-11 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Slate Medicines, Inc.
Free to see. No signup.
More on the people and the money behind Slate Medicines, Inc., from the filings we hold.
Pharmaceuticals raises by companies based in Massachusetts, filed in March 2026, largest first.
Get an email when Slate Medicines, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Slate Medicines, Inc. raises, hires or launches. No email unless you switch it on.
Watch Slate Medicines, Inc. →Get the full cited report on Slate Medicines, Inc.
What the filing shows about Slate Medicines, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Slate Medicines, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Slate Medicines, Inc.'s address as 200 Berkeley Street, 18TH Floor, Boston, MA 02116.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Slate Medicines, Inc. is a registered filer with the SEC (CIK 2117806) and has filed since 2026-03-11. 1 filing is on record, the latest on 2026-03-11.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Slate Medicines, Inc.'s Form D of 2026-03-11 names Andrew Levin, Cindy Xiong, Tim Lohoff and 3 more as its officers, directors or promoters.
Its new offerings report $10M sold across 1 offering, as its own filings state.
Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week. The dot is this raise, $10M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Andrew Levin is named as Director on the Form D that Slate Medicines, Inc. filed with the SEC on 11 March 2026, one of 6 people that filing names.
Cindy Xiong is named as Director on the Form D that Slate Medicines, Inc. filed with the SEC on 11 March 2026, one of 6 people that filing names.
Tim Lohoff is named as Director on the Form D that Slate Medicines, Inc. filed with the SEC on 11 March 2026, one of 6 people that filing names.
Neil Buckley is named as Executive Officer and Director on the Form D that Slate Medicines, Inc. filed with the SEC on 11 March 2026, one of 6 people that filing names.
Sara Pacheco is named as Executive Officer on the Form D that Slate Medicines, Inc. filed with the SEC on 11 March 2026, one of 6 people that filing names.
Gregory Oakes is named as Executive Officer on the Form D that Slate Medicines, Inc. filed with the SEC on 11 March 2026, one of 6 people that filing names.
6 people named on the filing — 3 holding an executive role and 3 as directors only.
Named as of the 2026-03-11 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Slate Medicines, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Slate Medicines, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Slate Medicines, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Slate Medicines, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Slate Medicines, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Slate Medicines, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/slate-medicines-inc-form-d-26000246